au.\*:("HOME, Philip D")
Results 1 to 16 of 16
Selection :
Validity of Meta-analysis in Diabetes: We Need to Be Aware of Its LimitationsHOME, Philip D.Diabetes care. 2013, Vol 36, Num 10, pp 3361-3367, issn 0149-5992, 7 p.Article
Treatment Satisfaction and Quality of Life With Insulin Glargine Plus Insulin Lispro Compared With NPH Insulin Plus Unmodified Human Insulin in Individuals With Type 1 DiabetesASHWELL, Simon G; BRADLEY, Clare; STEPHENS, James W et al.Diabetes care. 2008, Vol 31, Num 6, pp 1112-1117, issn 0149-5992, 6 p.Article
Factors Associated With Weight Gain in People With Type 2 Diabetes Starting on InsulinBALKAU, Beverley; HOME, Philip D; VINCENT, Maya et al.Diabetes care. 2014, Vol 37, Num 8, pp 2108-2113, issn 0149-5992, 6 p.Article
Personalized Management of Hyperglycemia in Type 2 Diabetes: Reflections from a Diabetes Care Editors' Expert ForumRAZ, Itamar; RIDDLE, Matthew C; LEROITH, Derek et al.Diabetes care. 2013, Vol 36, Num 6, pp 1779-1788, issn 0149-5992, 10 p.Article
Immune responses to Insulin aspart and biphasic Insulin aspart in people with type 1 and type 2 diabetesLINDHOLM, Anders; JENSEN, Lisbeth B; HOME, Philip D et al.Diabetes care. 2002, Vol 25, Num 5, pp 876-882, issn 0149-5992Article
Beyond Metformin: Safety Considerations in the Decision-Making Process for Selecting a Second Medication for Type 2 Diabetes Management Reflections From a Diabetes Care Editors' Expert ForumCEFALU, William T; BUSE, John B; DEL PRATO, Stefano et al.Diabetes care. 2014, Vol 37, Num 9, pp 2647-2659, issn 0149-5992, 13 p.Article
Insulin Degludec in Type 1 Diabetes: A randomized controlled trial of a new-generation ultra-long-acting insulin compared with insulin glargineBIRKELAND, Kare I; HOME, Philip D; MENEGHINI, Luigi F et al.Diabetes care. 2011, Vol 34, Num 3, pp 661-665, issn 0149-5992, 5 p.Article
Guidelines for the treatment and management of new-onset diabetes after transplantationWILKINSON, Alan; DAVIDSON, Jaime; NAICKER, Sarala et al.Clinical transplantation. 2005, Vol 19, Num 3, pp 291-298, issn 0902-0063, 8 p.Article
Comparison of a Multiple Daily Insulin Injection Regimen (Basal Once-Daily Glargine Plus Mealtime Lispro) and Continuous Subcutaneous Insulin Infusion (Lispro) in Type 1 Diabetes: A randomized open parallel multicenter studyBOLLI, Geremia B; KERR, David; THOMAS, Reena et al.Diabetes care. 2009, Vol 32, Num 7, pp 1170-1176, issn 0149-5992, 7 p.Article
Rosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type 2 diabetes (RECORD): a multicentre, randomised, open-label trialHOME, Philip D; POCOCK, Stuart J; BECK-NIELSEN, Henning et al.Lancet (British edition). 2009, Vol 373, Num 9681, pp 2125-2135, issn 0140-6736, 11 p.Article
A model of long-term metabolic progression of type 2 diabetes mellitus for evaluating treatment strategiesBAGUST, Adrian; EVANS, Marc; BEALE, Sophie et al.PharmacoEconomics (Auckland). 2006, Vol 24, pp 5-19, issn 1170-7690, 15 p., SUP1Article
Predictive and Explanatory Factors of Change in HbA1c in a 24-Week Observational Study of 66,726 People With Type 2 Diabetes Starting Insulin AnalogsHOME, Philip D; CHUNDUO SHEN; HASAN, Mohammad I et al.Diabetes care. 2014, Vol 37, Num 5, pp 1237-1245, issn 0149-5992, 9 p.Article
Endothelial Progenitor Cells in Subclinical Hypothyroidism: The Effect of Thyroid Hormone Replacement TherapyABDUL SHAKOOR, S. K; ALDIBBIAT, Ali; INGOE, Lorna E et al.The Journal of clinical endocrinology and metabolism. 2010, Vol 95, Num 1, pp 319-322, issn 0021-972X, 4 p.Article
Rosiglitazone evaluated for cardiovascular outcomes - : An interim analysisHOME, Philip D; POCOCK, Stuart J; BECK-NIELSEN, Henning et al.The New England journal of medicine. 2007, Vol 357, Num 1, pp 28-38, issn 0028-4793, 11 p.Article
Incidence and Prevalence of Unrecognized Myocardial Infarction in People With Diabetes: A substudy of the Rosiglitazone Evaluated for Cardiac Outcomes and Regulation of Glycemia in Diabetes (RECORD) studyMACDONALD, Michael R; PETRIE, Mark C; MCMURRAY, John J. V et al.Diabetes care. 2011, Vol 34, Num 6, pp 1394-1396, issn 0149-5992, 3 p.Article
Heart failure events with rosigtitazone in type 2 diabetes: data from the RECORD clinical trialKOMAJDA, Michel; MCMURRAY, John J. V; BECK-NIELSEN, Henning et al.European heart journal. 2010, Vol 31, Num 7, pp 824-831, issn 0195-668X, 8 p.Article